Literature DB >> 15805789

Role, epidemiology, and natural history of benign uterine mass lesions.

Ginny L Ryan1, Craig H Syrop, Bradley J Van Voorhis.   

Abstract

Mesh：

Year:  2005        PMID： 15805789     DOI： 10.1097/01.grf.0000159538.27221.8c

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  45 in total

1.  Combining split-and-merge and multi-seed region growing algorithms for uterine fibroid segmentation in MRgFUS treatments.

Authors:  Leonardo Rundo; Carmelo Militello; Salvatore Vitabile; Carlo Casarino; Giorgio Russo; Massimo Midiri; Maria Carla Gilardi
Journal:  Med Biol Eng Comput       Date:  2015-11-03       Impact factor: 2.602

2.  CYP1A1 genetic polymorphisms and uterine leiomyoma risk: a meta-analysis.

Authors:  Fen Wang; Jiying Chen; Lin Wang; Yulan Ma; Niyazi Mayinuer
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Authors:  Yulia Lakhman; Harini Veeraraghavan; Joshua Chaim; Diana Feier; Debra A Goldman; Chaya S Moskowitz; Stephanie Nougaret; Ramon E Sosa; Hebert Alberto Vargas; Robert A Soslow; Nadeem R Abu-Rustum; Hedvig Hricak; Evis Sala
Journal:  Eur Radiol       Date:  2016-12-05       Impact factor: 5.315

Review 4.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

5.  First experience of real-time elastography with transvaginal approach in assessing response to MRgFUS treatment of uterine fibroids.

Authors:  Chiara Marigliano; Giovanna Panzironi; Luisa Molisso; Alessandra Pizzuto; Federica Ciolina; Alessandro Napoli; Paolo Ricci
Journal:  Radiol Med       Date:  2016-09-01       Impact factor: 3.469

6.  Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes).

Authors:  E N Videan; W C Satterfield; S Buchl; M L Lammey
Journal:  Am J Primatol       Date:  2011-03-25       Impact factor: 2.371

7.  Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).

Authors:  Ussanee S Sangkomkamhang; Pisake Lumbiganon; Porjai Pattanittum
Journal:  Cochrane Database Syst Rev       Date:  2020-11-23

8.  Structured vs narrative reporting of pelvic MRI for fibroids: clarity and impact on treatment planning.

Authors:  Andrea Franconeri; Jieming Fang; Benjamin Carney; Almamoon Justaniah; Laura Miller; Hye-Chun Hur; Louise P King; Roa Alammari; Salomao Faintuch; Koenraad J Mortele; Olga R Brook
Journal:  Eur Radiol       Date:  2017-12-15       Impact factor: 5.315

Review 9.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

10.  Growth of uterine leiomyomata among premenopausal black and white women.

Authors:  Shyamal D Peddada; Shannon K Laughlin; Kelly Miner; Jean-Philippe Guyon; Karen Haneke; Heather L Vahdat; Richard C Semelka; Ania Kowalik; Diane Armao; Barbara Davis; Donna Day Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.